Myotonia congenita is an inherited condition in which skeletal muscles contract normally but are slow to relax, causing stiffness that is most noticeable when a person starts moving after rest. It results from mutations in the CLCN1 gene, which provides the blueprint for a chloride channel critical to muscle fiber excitability. Two forms exist: Thomsen disease, which follows an autosomal dominant inheritance pattern, and Becker disease, which is autosomal recessive.1PubMed Central. Physiology and pathophysiology of CLC-1: mechanisms of a chloride channel disease, myotonia Though the condition is rare and not life-threatening, its effects on daily movement, exercise, and even surgical safety make it worth understanding in detail.
What Goes Wrong at the Muscle Level
Every time a muscle fiber fires, a burst of electrical activity travels along its membrane. Chloride channels act as a kind of electrical brake, allowing chloride ions to flow in and stabilize the membrane once the contraction signal is done. In myotonia congenita, mutations in the CLCN1 gene produce faulty versions of the CLC-1 chloride channel, reducing the chloride conductance of skeletal muscle.2PubMed. Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita Without that stabilizing current, the muscle membrane stays excitable too long, firing repeatedly even after the brain’s “contract” signal has stopped. The result is a muscle that locks up temporarily, unable to relax on command.
The CLC-1 channel works as a pair of subunits joined together. Research on Thomsen’s disease, including analysis of the mutation carried by Dr. Julius Thomsen’s own family, showed that a single faulty subunit can dramatically inhibit the function of the paired normal subunit, explaining why one mutated copy of the gene is enough to cause symptoms in the dominant form.3PubMed Central. Multimeric structure of ClC-1 chloride channel revealed by mutations in dominant myotonia congenita (Thomsen) In Becker disease, the mutations tend to produce less interference with the partner subunit, so both copies of the gene need to be affected before chloride conductance drops enough to cause symptoms.
Thomsen Disease Versus Becker Disease
Although both forms trace back to CLCN1 mutations, they differ in several practical ways that matter to patients and their families.4PubMed Central. Myotonia congenita: novel mutations in CLCN1 gene
- Age of onset: Thomsen disease usually appears in infancy or early childhood, while Becker disease tends to surface later, often in late childhood or adolescence.
- Severity: Becker disease is generally more severe, with more pronounced stiffness and an additional symptom that Thomsen patients rarely experience: transient bouts of muscle weakness.
- Inheritance pattern: In Thomsen disease, a child needs only one mutated copy of CLCN1 (from one parent) to develop symptoms. In Becker disease, both copies must carry a mutation, meaning both parents are typically unaffected carriers.
- Prevalence: Becker disease is more common overall, partly because recessive mutations in CLCN1 can circulate silently in carrier populations for generations without causing symptoms.
The genetic boundary between the two forms is not always clean-cut. Some CLCN1 mutations have been reported in families with both dominant and recessive patterns, depending on how much the specific mutation disrupts channel function.5PLOS ONE. CLCN1 Mutations in Czech Patients with Myotonia Congenita, In Silico Analysis of Novel and Known Mutations in the Human Dimeric Skeletal Muscle Chloride Channel This overlap can make genetic counseling tricky for families who carry a mutation with uncertain dominance behavior.
What the Stiffness Actually Feels Like
The hallmark of myotonia congenita is skeletal muscle stiffness that strikes hardest at the start of movement after a period of rest. You sit down for twenty minutes, stand up, and your legs feel wooden. You reach for a doorknob, and your hand grips it fine but refuses to let go for a few seconds. Cold environments tend to make it worse, as low temperatures further slow the already sluggish chloride channels.
One of the most characteristic features is the warm-up phenomenon. After the first few stiff movements, repeated contractions gradually loosen the muscles, and within a minute or two the stiffness fades considerably. For many people with myotonia congenita, the trick is simply getting past those first awkward seconds. This warm-up effect distinguishes the condition from some other forms of myotonia, like paramyotonia congenita, where continued activity makes stiffness worse rather than better.
Patients with Becker disease face an additional challenge. Beyond the stiffness, they can experience sudden bouts of transient weakness, where a muscle group that was working fine suddenly gives way.6PubMed Central. The mechanism underlying transient weakness in myotonia congenita This weakness is distinct from fatigue. It can be debilitating and unpredictable, and despite years of study, the exact mechanism remained poorly understood until relatively recent research pointed to the way mutant chloride channels interact with potassium buildup during sustained activity. The weakness episodes tend to resolve on their own but can last long enough to cause falls or difficulty with tasks requiring sustained grip.
The Herculean Physique
People with myotonia congenita sometimes develop strikingly muscular builds, particularly in the legs, shoulders, and neck, even without intensive weight training. This “Herculean” appearance results from the continuous involuntary contractions their muscles undergo throughout the day. In effect, their muscles are doing low-grade resistance exercise around the clock. One case report described a 29-year-old professional bodybuilder with myotonia congenita who had generalized muscle hypertrophy without ever using anabolic steroids, with clinicians noting that the persistent involuntary contractions likely acted as a form of continuous resistance training.7PubMed Central. Bodybuilding championships and myotonia congenita
This muscular appearance can be a double-edged sword. On one hand, it means people with the condition often look strong and healthy, which can make it harder for them to be taken seriously when they describe the stiffness and weakness they deal with daily. On the other hand, the underlying muscle mass is generally functional. Strength itself is usually normal or even above average in myotonia congenita. The problem is not weakness at rest but the delay in getting muscles to cooperate when you first start moving.
Getting a Diagnosis
Myotonia congenita is often underdiagnosed or misdiagnosed, partly because stiffness on its own is a vague complaint and partly because the condition is rare enough that many clinicians have never seen a case. The diagnostic workup usually involves a combination of clinical history, electromyography, and genetic testing.
On electromyography, the classic finding is myotonic discharges: continuous runs of electrical potentials that wax and wane in both frequency and amplitude, producing a characteristic sound sometimes compared to a dive-bomber or revving motorcycle engine through the EMG speaker.8Muscle & Nerve. Myotonia: Recognition, Evaluation, and Differential Diagnosis These discharges confirm that the muscle membrane is hyperexcitable but do not pinpoint the cause, since myotonic discharges also occur in myotonic dystrophy and sodium channel myotonias.
Genetic testing of the CLCN1 gene is what nails down the diagnosis. With modern sequencing, clinicians can identify the specific mutation and determine whether it follows a dominant or recessive pattern. This matters not just for the individual patient but for family planning: knowing whether a mutation is dominant or recessive changes the odds that a child will be affected.
Telling It Apart from Myotonic Dystrophy
The condition most easily confused with myotonia congenita is myotonic dystrophy, especially type 2. Both cause muscle stiffness and produce myotonic discharges on EMG. The critical difference is that myotonic dystrophy is a progressive, multisystem disease: it attacks the heart, the eyes, the endocrine system, and eventually the muscles themselves waste away. Myotonia congenita, by contrast, is essentially a muscle-only condition. The muscles stiffen up but do not deteriorate over time, and life expectancy is normal.
In rare cases, both conditions can coexist in the same family. Researchers documented a family in which affected members carried both a CLCN1 mutation and a CCTG repeat expansion in the CNBP gene responsible for myotonic dystrophy type 2. The CLCN1 mutation appeared to worsen the severity of myotonia beyond what the dystrophy gene alone would cause, contributing to pronounced variability in symptoms among family members.9PubMed Central. Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene This kind of overlap is unusual but underscores why genetic testing, rather than clinical impression alone, is important for a correct diagnosis.
Drug Treatment and How Well It Works
The first-line medication for myotonia congenita is mexiletine, an oral sodium channel blocker originally developed as a heart rhythm drug. It works by dampening the hyperexcitability of the muscle membrane, reducing the repetitive firing that causes stiffness. In a randomized, double-blind, placebo-controlled crossover trial, mexiletine brought the median stiffness score on a visual analog scale down from about 71 to 16, while stiffness on placebo barely budged (from 81 to 78). The effect was statistically significant, and the drug was well tolerated.10PubMed. Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study Most patients notice a meaningful reduction in stiffness within the first week or two of treatment.
Not everyone responds well to mexiletine, and some people cannot tolerate its gastrointestinal side effects. For these patients, several alternatives exist, though the evidence base is thinner. Lamotrigine, an anticonvulsant, is the only other drug whose effectiveness in non-dystrophic myotonia has been demonstrated in a rigorous randomized controlled trial.11PubMed Central. Pharmacological therapy of non-dystrophic myotonias – Section: Alternative drugs to mexiletine Other sodium channel blockers, including flecainide, ranolazine, and propafenone, have shown promise in small series and preclinical work but lack the controlled trial data to recommend them broadly.12The Lancet Neurology. Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial – Section: Discussion Acetazolamide, a carbonic anhydrase inhibitor better known for treating altitude sickness and glaucoma, has also shown some efficacy and is occasionally used off-label.13PubMed Central. Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine – Section: RESULTS
The choice among these drugs sometimes comes down to the specific mutation. Certain CLCN1 variants appear to confer reduced sensitivity to mexiletine, which may explain why some patients do better on flecainide or lamotrigine.14PubMed Central. Pharmacological therapy of non-dystrophic myotonias – Section: Alternative drugs to mexiletine As genetic testing becomes standard in the diagnostic workup, there is growing interest in matching specific mutations to specific drugs, a move toward precision medicine in a field that has largely relied on one-size-fits-all prescribing.
Anesthesia and Surgical Risk
One of the most consequential practical concerns for people with myotonia congenita has nothing to do with daily stiffness. It involves what happens when they need surgery. Certain anesthetic agents, particularly succinylcholine (a depolarizing muscle relaxant commonly used during intubation), can trigger severe and prolonged muscle contractions in patients with the condition. The resulting spasm can make it impossible to ventilate the patient and may be mistaken for malignant hyperthermia, a different and far more dangerous emergency.
The clinical picture during an anesthetic crisis can range from intense masseter spasm (the jaw clenching shut) to full-body rigidity.15PubMed Central. Pathophysiologic and anesthetic considerations for patients with myotonia congenita or periodic paralyses Cold operating rooms and shivering during recovery can further aggravate myotonia. For these reasons, anesthetic guidelines for myotonia congenita emphasize avoiding depolarizing muscle relaxants, keeping the patient warm, and having the care team aware of the diagnosis before induction. A medical alert bracelet or preoperative conversation with the anesthesiologist is not overkill for someone with this condition; it is genuinely important.
Living with the Condition Day to Day
Because myotonia congenita does not shorten life or cause progressive muscle wasting, many people with the condition lead fully active lives. The stiffness is at its worst during transitions: standing from sitting, starting to walk after waiting at a traffic light, reaching for a glass after resting your hand. Once muscles warm up, most activities proceed normally. Some people with the condition are competitive athletes, and the muscular build that accompanies the disease can even be an advantage in strength-based sports.
That said, the condition is not without real frustrations. Cold weather makes stiffness worse, so winter mornings can be miserable. Sudden movements in an emergency, like slamming on the brakes or catching yourself during a stumble, may be impaired because the first contraction is the stiffest. People with Becker disease have the additional worry of transient weakness episodes, which can make activities like climbing stairs or carrying heavy objects unpredictable.
Psychologically, the invisible nature of the condition can be isolating. You look strong, your muscles are large, and most of the time you move just fine. But in certain moments you freeze up, and explaining that to coworkers, coaches, or strangers can feel like convincing someone of something they cannot see. Support communities and patient registries for non-dystrophic myotonias have grown in recent years, giving people a place to share practical strategies and push for more research funding.
The Myotonic Goat and Why It Matters
Long before the genetics of myotonia congenita were worked out in humans, a naturally occurring animal model helped scientists understand the role of chloride channels in muscle. Myotonic goats, sometimes called “fainting goats,” have been bred for centuries. When startled, their skeletal muscles lock up and the animals topple over stiffly. Unlike true fainting, they remain fully conscious. Researchers eventually traced the goats’ condition to a single nucleotide change in the goat version of the CLC-1 chloride channel gene, substituting a proline for a conserved alanine in the channel’s tail end.16PubMed. Molecular basis for decreased muscle chloride conductance in the myotonic goat
The myotonic goat provided early proof that reduced chloride conductance alone was sufficient to produce myotonia, a finding that guided the search for CLCN1 mutations in human patients. Today, the goats are more of a curiosity than a research workhorse, but they remain a vivid illustration of how a single genetic change can dramatically alter the way muscles behave. If you have ever seen a video of a startled goat going rigid and falling sideways, you have seen a close analogue of what happens in a human leg with myotonia congenita during those first stiff steps after rest, just compressed into a more dramatic time window.
Pregnancy, Hormones, and Symptom Fluctuation
Symptom severity in myotonia congenita is not fixed across a person’s lifetime. Hormonal changes, physical stress, and even emotional state can modulate stiffness. Women with the condition sometimes report that symptoms change during pregnancy or around menstruation, likely because sex hormones influence ion channel expression and muscle membrane excitability. One clinical case described a 56-year-old woman referred to a neurogenetics clinic with a history of stiffness and transient weakness; needle EMG confirmed myotonia, and muscle biopsy showed no evidence of dystrophy, consistent with myotonia congenita rather than a progressive muscular disease.17Nature Reviews Neurology. Myotonia congenita—a cause of muscle weakness and stiffness The case highlighted how the condition can present or worsen later in life, particularly around hormonal transitions like menopause, and how it can be mistaken for other neuromuscular conditions when it surfaces in middle age.
Children with Thomsen disease may notice their symptoms become more manageable as they enter adolescence and learn to warm up their muscles instinctively before demanding activities. Conversely, some adults report that stiffness increases during periods of prolonged inactivity, illness, or emotional stress. These fluctuations do not reflect disease progression; the underlying mutation is static. What changes is the physiological context in which the mutant channels operate.